new generation broader indications worldwide event

NEW GENERATION
BROADER INDICATIONS
WORLDWIDE EVENT
Rhe
An exclusive
YESTERDAY…
THE RHEALBA® OAT SEED...
elected from among over 80 different
S
varieties of oat for its unrivalled purity
Its soothing, anti-irritant, nourishing and
skin-repair virtues
emonstrated by numerous scientific
D
research studies
In-depth knowledge of oat cultivation and
research experience acquired over more
than 20 years
alba
®
Oat Plantlets
A-DERMA discovery
TODAY...
THE RHEALBA® OAT PLANTLET…
election of young Rhealba ® Oat
S
shoots
A t the first stages of full growth
or unique properties that have
F
not yet been exploited
2 international patents applied for
Rhe
T h e re vo
1
M
aximum efficacy of
specific active ingredients
Harvested at precisely the right moment,
when actives are at their maximum
concentration
Flavonoids = anti-inflammatory activity
Saponins = immunomodulating activity
alba
®
Oat Plantlets
ol ut io n i s u n d e r w ay
2
T
otal safety of the
Plantlet extract
• Absence o f d e t e c t a b l e p r o t e i n
in the Pla n t l e t e x t r a c t
< 0 , 0 5 ppm (par ts per million) in the finis hed pr odu c t
• P a t e nt ap p l i e d fo r the us e o f an
extract f r o m t h e a e r i a l p a r t o f t h e c e r e a l
or the ps e u d o c e r e a l ( e x c l u d i n g t h e
se e ds) b y p e o p l e a l l e r g i c t o c e r e a l
s e e d p rot e i n s .
NEW GENER
Extract of Rhealba®
Oat Plantlets
+
Filaxerine®
Combination of an original
filaggrin-inducing active and
essential fatty acids Omega 6
is today the first and only derm
on all dry skin and atopic derm
RATION
• A nti-inflammatory
• Immunomodulating activity
•R
estores the skin barrier
• Improves skin dryness
mo-cosmetic product to have an effect
matitis parameters
NEW GENER
BROADER INDICATIONS
ATOPIC SKIN
ATOPIC AND VERY
DRY SKIN
Prospective customers x3
For easier and more frequent product
recommendation at the point of sale
RATION
CLEAR OBJECTIVES
•R
einforce our position as
INCONTESTABLE LEADER
in the Atopic Skin market
•B
ecome the NEW LEADER
in the Very Dry Skin market
Already, one
product sold
in the world every 10 seconds
New packaging in the line
CURRENT
Enter with the
product name
to make product
recommendation
easier
NEW
Improve the
clarity and
readability of
claims
Respect the
right height for
improved shelf
presentation
(strip)
Highlight the
innovation
aspect
e with objectives
Greater impact
Greater simmetry on shelves
Improved product-offering differentiation
and segmentation
A Global Event
AN INTERNATIONAL
PHARMACEUTICAL LAUNCH
France, Spain, Italy, Portugal, Greece and Belgium
September 2009
All other international territories
As of January 2010
More than 50 countries throughout
the world
AN UNPRECEDENTED MOBILIZATION
OF PRESCRIBERS
isits geared exclusively to the new generation
V
Exomega
lobal launch symposium at the EADV in Berlin in
G
October 2009
linical study (in more than 3000 patients) on all
C
continents
Major publications to come
Rhealba® Oat Plantlets (Efficacy and Safety)
xomega Cream (International multicenter
E
clinical study versus placebo)
A 100% EXOMEGA wo
A strong identity built around the na
A SPECIAL-EVENT WINDOW DISPLAY
P romotion of EXOMEGA Cream and Oil
Promotion of Rhealba ® Oat Plantlets
A s t r o n g image to catch the
ey es o f p as s e rs - b y
orld in your pharmacy
aturalness of Rhealba ® Oat Plantlets
AN ENHANCED SHELF SPACE
Promotion of EXOMEGA Cream
3 clearly established claims
A shelf strip highlighting indications
A n a pp e a l t hat will g uid e
y o u r c u s tome rs
A promotional and qualitat
A TURNKEY AISLE END DISPLAY
(MATERIAL INSTALLED FOR 3, 4 OR 5 SHELVES)
tive product store display
A «DIDACTIC» HOT SPOT
(FLOOR UNIT DELIVERED EMPTY
FOR 24 UNITS OF EACH REFERENCE)
NEW GENER
A TRIPLE ACTION
Filaxerine®
barrier repair
action
Rhealba® Oat Plantlets
immunomodulating
and anti-inflammatory
Filaxerine ®
Acid (10-HDA) + Omega 6 fatty acids
Extract of Rhealba ®
Oat Plantlets
A complementary action for
restructuring the skin barrier
Anti-inflammatory and
immunomodulating action
Natural immunomodulator :
Rhealba ® Oat Plantlets (saponins)
Correction of the
ceramide, fatty acid and
sterol deficiencies of
intercellular lipids
Normalization
of corneocyte
differentiation
Inhibits the release of over-expressed
interleukins (IL2,IL4,IL5,IL13) in atopic
dermatitis
« Boosts » regulatory T lymphocytes deficient
in atopic subjects
Anti-inflammatory :
Rhealba ® Oat Plantlets (flavonoids)
Inhibits the release of prostacyclin
Inhibits the release of leukotrienes
RATION
CLINICALLY PROVEN EFFICACY
IN ATOPIC CHILDREN (over 6 months of age) AND ADULTS UNDER
DERMATOLOGICAL AND PEDIATRIC CONTROL
Cream
-33 % -66 %
Effective against Dryness
- 62 %
- 79 %
Easy to apply 98 %
and itching After applying, skin is
soft
100 %
protected
100 %
soothed
98 %
and moisturized
94 %
17,9
11,9
6,1
Significant p<0,05
Cleansing Oil
Effective against Dryness - 43 %
- 96 %
Easy to apply
100 %
After applying, skin is
soft 100 %
soothed
98 %
moisturized
96 %
and comfortable 96 %
and itching -41 % -58 %
17,6
10,3
7,3
Significant p<0,05
NEW GEN ER AT I O N
T he k ey s to g u arant e e d s ucce s s
OUR COMMITMENTS
Train your team
Large numbers of samples for the ‘leading’ references (Cream/Oil)
Setting up of shelf displays
Setting up of the special-event window display
Provision of end-display material or didactic Hot Spot
YOUR COMMITMENTS
Mobilize staff to recommend Exomega (Ambassador)
ouble the Exomega shelf space
D
(allocate 1 additional A-Derma shelf)
Install the window display for 1 month
Develop sales as of September
05/09 - Elixir 05 61 84 52 09
Install the aisle end display for 1 month or
allocate a permanent area for the didactic Hot Spot